FDA Unveils 9 Drugs to Receive Expedited Reviews Under National Priority Voucher Program
Food and Drug Administration headquarters in White Oak, Maryland, on Aug. 29, 2020. Andrew Kelly/Reuters The Food and Drug Administration (FDA) on Oct. 16 announced the first batch of drugs that will receive expedited reviews under the Commissioner’s National Priority Voucher (CNPV) pilot program. “Voucher recipients will receive a decision within 1–2 months following filing